Münchener Rück AG
5-year stock timeline
Münchener Rück navigated the 2020–2021 COVID shock while preserving dividends and maintaining regular investor dialogue around near-term outlook. The 2022 shift to IFRS 17 accounting coincided with renewed scrutiny of natural-catastrophe volatility and its earnings drag; an Investor Day in December that year acknowledged the pressure on results and guidance.
From 2023 onward, management executed Ambition 2025 with material force. Shareholder distributions rose meaningfully—dividend increases compounded year-on-year through 2025—while strategic moves included full acquisition of NEXT Insurance in March 2025. A planned CEO transition brought Christoph Jurecka in to succeed Joachim Wenning starting 1 January 2026.
Investor framing evolved with the company. The early years cast Munich Re as a defensive reinsurance compounder; capital strength and dividend reliability were the story. By 2022–2023, that narrative bent toward cyclicality tempered by resilience as markets recalibrated around nat-cat exposure and accounting shifts. Into 2024–2026, the emphasis sharpened on execution—Ambition 2025 delivery, rising per-share distributions, management succession—lifting focus toward tangible returns and financial discipline.
Technically, 2020–2021 saw pandemic disruption give way to recovery as fundamentals stabilized and company guidance supported a rebound. The 2022–early 2023 period brought repricing and volatility, with nat-cat losses and earnings uncertainty producing range-bound trading and material drawdowns. From 2023 into 2026, consolidation evolved into gradual rerating as dividend per share climbed and share count edged lower, anchoring stronger absolute performance into the current level of €483.4.
Key risks and downside factors
Münchener Rück operates as a global diversified reinsurer in a concentrated market dominated by a handful of large, capital-intensive competitors—Swiss Re, Hannover Rück, and SCOR among them. Recent consolidation, notably Covéa's acquisition of PartnerRe, has reshaped the competitive terrain around pricing, capacity, and strategic positioning. The business faces familiar pressures: catastrophe losses that can swing results materially, the cyclical nature of underwriting and reserves, volatility in investment returns, and the constant weight of regulatory and rating-agency capital demands. These aren't unique to Munich Re, but they're worth watching in how the company navigates them.
- Large natural-catastrophe or accumulation events can produce sudden, material underwriting losses and earnings volatility, putting real pressure on capital and reinsurance programs.
- Reserve shortfalls in long-tail life and medical liabilities can force significant additional provisions and erode surplus.
- Weak investment returns or mark-to-market losses on fixed income and equity portfolios compress the investment income and capital ratios available to support underwriting [12][11].
- Regulatory pressures, rating-agency scrutiny, and consolidation dynamics—visible in deals like PartnerRe's acquisition by Covéa—can push up capital costs, tighten available capacity, or nudge companies toward strategic shifts they might not have chosen otherwise.
Competitive landscape
Munich Re stands as the world's largest reinsurer, competing directly with Swiss Re, Hannover Re, Berkshire Hathaway's reinsurance operations, SCOR and RGA across property/casualty and life insurance lines. The competitive landscape extends to Lloyd's market participants, specialist reinsurers and alternative-capital providers—all of which exert pricing pressure in niche segments and large catastrophe markets. The company's risk profile centers on catastrophe exposure, underwriting and reserving volatility, sensitivity to investment returns and interest rates, and the constraints imposed by regulatory capital requirements.
| Company | Ticker |
|---|---|
| Swiss Re Ltd | SREN.SIX |
| Hannover Rück SE | HNR1.XETRA |
| Reinsurance Group of America Inc | RGA.NYSE |
Private competitors
- Lloyd's of London
- Specialist ILS and alternative-capital managers (insurance-linked securities funds)
Get More Stock Analyses Like This
Receive hand-picked stock recommendations with detailed analyses every week
Start Free TrialPerformance Figures of Münchener Rück AG
Relative Performance vs Benchmarks
| Period | Münchener Rück AG | vs DAX | vs S&P 500 (SPY) |
|---|---|---|---|
| 1M | -10.70% | -10.94% | -14.23% |
| 3M | -5.47% | -3.20% | -12.96% |
| 6M | -4.87% | -10.86% | -16.84% |
| 1Y | -13.12% | -14.95% | -38.30% |
| 3Y | +60.20% | +9.82% | -21.94% |
| 5Y | +145.93% | +87.38% | +56.60% |
Get More Stock Analyses Like This
Receive hand-picked stock recommendations with detailed analyses every week
Start Free TrialHistorical valuation trends
How the company’s key valuation ratios (P/E, P/S, P/B and P/CF) have evolved over time compared to today.
| Period | P/E Ratio | P/S Ratio | P/B Ratio | P/CF Ratio |
|---|---|---|---|---|
| Current | 9.2 | 0.9 | 1.8 | 48.7 |
| 1Y ago | 16.4 | 1.2 | 2.3 | 24.1 |
| 3Y ago | 8.5 | 0.7 | 1.5 | -6.1 |
| 5Y ago | 20.9 | 0.6 | 1.1 | 4.6 |
Frequently Asked Questions
Where is the Münchener Rück AG stock traded?
What does Münchener Rück AG do?
What are the key metrics for MUV2.XETRA?
How has Münchener Rück AG's stock price performed?
How is MUV2.XETRA valued?
Does MUV2.XETRA pay dividends?
What are the key risks when investing in MUV2.XETRA?
- Large natural-catastrophe or accumulation events can produce sudden, material underwriting losses and earnings volatility, putting real pressure on capital and reinsurance programs.
- Reserve shortfalls in long-tail life and medical liabilities can force significant additional provisions and erode surplus.
- Weak investment returns or mark-to-market losses on fixed income and equity portfolios compress the investment income and capital ratios available to support underwriting [web:12][web:11].
- Regulatory pressures, rating-agency scrutiny, and consolidation dynamics—visible in deals like PartnerRe's acquisition by Covéa—can push up capital costs, tighten available capacity, or nudge companies toward strategic shifts they might not have chosen otherwise.
Who are the main competitors of Münchener Rück AG?
- Swiss Re Ltd (SREN.SIX)
- Hannover Rück SE (HNR1.XETRA)
- Reinsurance Group of America Inc (RGA.NYSE)
When does Münchener Rück AG report earnings?
Key Metrics
Valuation Metrics
Profitability Metrics
Growth Metrics
Dividend history
Long-term record of paid dividends (amount per share and dividend yield at the time of payment).
| Year | Dividend | Yield at payment | Avg. yield |
|---|---|---|---|
| 2026 | 24.00 EUR | 4.56% | 4.24% |
| 2025 | 20.00 EUR | 3.32% | |
| 2024 | 15.00 EUR | 3.54% | |
| 2023 | 11.60 EUR | 3.43% | |
| 2022 | 11.00 EUR | 4.56% | |
| 2021 | 9.80 EUR | 3.81% | |
| 2020 | 9.80 EUR | 4.44% | |
| 2019 | 9.25 EUR | 4.15% | |
| 2018 | 8.60 EUR | 4.35% | |
| 2017 | 8.60 EUR | 4.54% | |
| 2016 | 8.25 EUR | 4.74% | |
| 2015 | 7.75 EUR | 4.06% | |
| 2014 | 7.25 EUR | 4.36% | |
| 2013 | 7.00 EUR | 4.41% | |
| 2012 | 6.25 EUR | 5.34% |
Earnings history & estimates
Historical earnings performance shows how consistently the company meets or exceeds analyst expectations. Forward estimates provide insight into expected profitability and growth trajectory.
Historical earnings performance
Upcoming earnings report
Analyst estimates for upcoming periods
Key financial figures
Selected income statement, balance sheet and cash flow figures. Annual and quarterly, based on reported IFRS/GAAP financials.
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | 69.30B | 42.31B | 70.46B | 39.71B | 63.86B |
| Operating income (EBIT) | 10.22B | 9.24B | 3.79B | 10.52B | 8.53B |
| Net income | 6.12B | 5.68B | 2.86B | 5.31B | 2.93B |
| Free cash flow | 1.10B | 2.83B | 2.40B | -7.64B | 5.23B |
| Total assets | 279.93B | 286.51B | 273.79B | 298.57B | 312.40B |
| Equity | 33.25B | 32.64B | 29.65B | 21.06B | 30.83B |
| Net debt | 1.93B | 205.00M | -3.86B | -2.87B | -1.98B |
PWP Leeway UG (haftungsbeschränkt)
